TIDMGWP 
 
RNS Number : 8094Y 
GW Pharmaceuticals PLC 
10 September 2009 
 

GW Pharmaceuticals to present at Rodman & Renshaw Annual Global Investment 
Conference 
 
 
Porton Down, UK, 10 September 2009: GW Pharmaceuticals plc (AIM: GWP) announces 
that its Managing Director, Justin Gover, will be presenting at the Rodman & 
Renshaw Annual Global Investment Conference in New York on Thursday, September 
10, 2009 at 3.40 pm EDT (8.40 pm BST). 
 
 
Investors may access a live webcast of the presentation at www.gwpharm.com on 
the presentations page under the Investor Relations tab. An archived version of 
the presentation will be available later that day. 
 
 
  Enquiries: 
 
 
+-------------------------------------+------------------------------------+ 
| GW Pharmaceuticals plc              |            Today: +44 20 7831 3113 | 
+-------------------------------------+------------------------------------+ 
| Justin Gover, Managing Director     |       Thereafter: + 44 1980 557000 | 
+-------------------------------------+------------------------------------+ 
|                                     |                                    | 
+-------------------------------------+------------------------------------+ 
| Financial Dynamics                  |              Tel: +44 20 7831 3113 | 
+-------------------------------------+------------------------------------+ 
| Ben Atwell, John Dineen             |                                    | 
+-------------------------------------+------------------------------------+ 
 
 
Notes to Editors 
 
 
About GW 
GW was founded in 1998 and listed on the AIM, a market of the London Stock 
Exchange, in June 2001. Operating under license from the UK Home Office, the 
company researches and develops cannabinoid pharmaceutical products for patients 
who suffer from a range of serious ailments, in particular multiple sclerosis 
and cancer pain. GW has assembled a large in-house scientific team with 
expertise in cannabinoid science as well as experience in the development of 
both plant-based prescription pharmaceutical products and medicines containing 
controlled substances. GW occupies a world leading position in cannabinoids and 
has developed an extensive international network of the most prominent 
scientists in the field. For more information, visit www.gwpharm.com 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 MSCDGGGLVLDGLZM
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Gw Pharmaceuticals Charts.
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Gw Pharmaceuticals Charts.